What are the recommended management strategies for pneumonia in children, including supportive care, outpatient and inpatient antibiotic regimens with dosing, and criteria for hospitalization?

Management of Pneumonia in Children

For outpatient management of pediatric community-acquired pneumonia, amoxicillin 90 mg/kg/day divided into 2 doses is the first-line treatment for children under 5 years with presumed bacterial pneumonia, while children ≥5 years should receive the same dose of amoxicillin, with consideration of adding a macrolide if atypical pathogens cannot be excluded. 1

Outpatient Antibiotic Regimens

For Presumed Bacterial Pneumonia

Children <5 years:

• First-line: Amoxicillin 90 mg/kg/day divided into 2 doses (oral) 1
• Alternative: Amoxicillin-clavulanate (amoxicillin component 90 mg/kg/day in 2 doses) 1

Children ≥5 years:

• First-line: Amoxicillin 90 mg/kg/day in 2 doses (maximum 4 g/day) 1
• For children who cannot distinguish bacterial from atypical pneumonia clinically, add a macrolide to the β-lactam 1
• Alternative: Amoxicillin-clavulanate (amoxicillin component 90 mg/kg/day in 2 doses, maximum 4000 mg/day) 1

For Presumed Atypical Pneumonia

All ages:

• First-line: Azithromycin 10 mg/kg on day 1, then 5 mg/kg/day once daily on days 2-5 (maximum 500 mg day 1, then 250 mg days 2-5) 1
• Alternatives:
  • Clarithromycin 15 mg/kg/day in 2 doses for 7-14 days (maximum 1 g/day) 1
  • Erythromycin 40 mg/kg/day in 4 doses 1
  • Doxycycline for children >7 years 1

Treatment Duration

Recent evidence supports 3-5 days of antibiotic therapy for uncomplicated bacterial pneumonia in otherwise healthy children in high-income settings 2. This represents a shift from traditional 10-day courses, though many centers still use longer durations 3.

Inpatient Antibiotic Regimens

For Fully Immunized Children (Hib and PCV vaccines) with Minimal Local Penicillin Resistance

Presumed bacterial pneumonia:

• First-line: Ampicillin (150-200 mg/kg/day IV every 6 hours) or Penicillin G (200,000-250,000 U/kg/day IV every 4-6 hours) 1
• Alternatives: Ceftriaxone (50-100 mg/kg/day IV every 12-24 hours) or Cefotaxime (150 mg/kg/day IV every 8 hours) 1
• Add vancomycin or clindamycin if community-associated MRSA is suspected 1

If atypical pneumonia suspected:

• Add azithromycin to the β-lactam therapy 1
• Alternatives: clarithromycin, erythromycin, or doxycycline (>7 years) 1

For Incompletely Immunized Children or Significant Local Penicillin Resistance

Presumed bacterial pneumonia:

• First-line: Ceftriaxone or cefotaxime (doses as above) 1
• Add vancomycin or clindamycin for suspected CA-MRSA 1
• Alternative: levofloxacin with vancomycin/clindamycin for CA-MRSA 1

Specific Pathogen-Directed Therapy

For highly resistant S. pneumoniae (MIC ≥4.0 μg/mL):

• Preferred: Ceftriaxone 100 mg/kg/day IV every 12-24 hours 1
• Alternatives: High-dose ampicillin (300-400 mg/kg/day IV every 6 hours), levofloxacin, or linezolid 1

For CA-MRSA (clindamycin-susceptible):

• Preferred: Vancomycin (40-60 mg/kg/day IV every 6-8 hours, targeting AUC/MIC >400) or clindamycin (40 mg/kg/day IV every 6-8 hours) 1
• Alternative: linezolid 1

Criteria for Hospitalization

While the guidelines don't provide explicit severity criteria, hospitalization should be considered for:

• Infants and young children with respiratory distress (tachypnea, retractions, hypoxia)
• Inability to maintain oral hydration
• Failure of outpatient therapy (no improvement within 48-72 hours)
• Suspected complications (pleural effusion, empyema)
• Underlying chronic conditions or immunocompromise
• Social factors preventing adequate outpatient care

Children with lower chest retractions but no hypoxia can be treated with oral amoxicillin on an outpatient basis 4, avoiding unnecessary hospitalization.

Supportive Care

Oxygen Therapy

• Provide supplemental oxygen for hypoxic children to maintain adequate oxygen saturation
• High-flow nasal cannula therapy is an emerging intervention for moderate respiratory distress 5

Fluid Management

• Ensure adequate hydration while avoiding fluid overload
• IV fluids may be necessary for children unable to maintain oral intake

Monitoring

• Children on adequate therapy should show clinical improvement within 48-72 hours 1
• For children who deteriorate or show no improvement within 48-72 hours, further investigation is mandatory 1

Important Caveats

Penicillin Allergy

The negative impact of inaccurate penicillin allergy labels has been emphasized 2. For children with reported non-serious allergic reactions to amoxicillin, options include:

• Trial of amoxicillin under medical observation
• Oral cephalosporin (cefpodoxime, cefprozil, cefuroxime) under supervision
• Levofloxacin, linezolid, or clindamycin (if susceptible) 1

Exercise particular caution with bacteremic pneumococcal pneumonia due to potential secondary sites of infection including meningitis 1.

Antimicrobial Stewardship

• Penicillins remain the first-line choice and should not be replaced by broader-spectrum agents without clear indication 6
• Newer drugs for multidrug-resistant organisms should be used judiciously to prevent further resistance 4
• Non-β-lactam agents like vancomycin have not been shown more effective than third-generation cephalosporins for current levels of pneumococcal resistance in North America 1

Parapneumonic Effusions

• History and physical examination may suggest effusion, but chest radiography should confirm pleural fluid presence 1
• Surgical management should be considered for moderate effusions with worsening clinical course and large effusions with or without loculations 7